Notably, FGFR2 fusions and rearrangements are predominantly observed in intrahepatic cholangiocarcinoma (iCCA) and occur in 10–20% of patients [116,117,118,119]. Here, FGFR2 is linked to intrahepatic cholangiocarcinoma.